2 Registered trials

0 Recruiting

2 Unique sponsors

3 Unique IMPs

2 Commercial trials

Drug classes (ATC)

N Neurology/Psychiatry (ATC N) 2

L Oncology (ATC L) 1

Mechanism of action (INN-stem analysis)

HDAC inhibitor 1 substance

IMiD 1 substance

Colony-stimulating factor 1 substance

Phase III

Phase II

Phase III: 1 Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Phase III

1 trial

Phase II

2 trials

Sponsor activity

Sponsor	Type	Trials	Phases	Recruiting
Viracta Therapeutics Inc.	Commercial	2	Phase II	0
Celgene Corp.	Commercial	1	Phase III	0

New trials by year

2021

2024